Abstract:MOTIVATION: Drug repositioning, which aims to identify new indications for existing drugs, offers a promising alternative to reduce the total time and cost of traditional drug development. Many computational strategies for drug repositioning have been proposed, which are based on similarities among drugs and diseases. Current studies typically use either only drug-related properties (e.g. chemical structures) or only disease-related properties (e.g. phenotypes) to calculate drug or disease similarity, respectively, while not taking into account the influence of known drug-disease association information on the similarity measures.RESULTS: In this article, based on the assumption that similar drugs are normally associated with similar diseases and vice versa, we propose a novel computational method named MBiRW, which utilizes some comprehensive similarity measures and Bi-Random walk (BiRW) algorithm to identify potential novel indications for a given drug. By integrating drug or disease features information with known drug-disease associations, the comprehensive similarity measures are firstly developed to calculate similarity for drugs and diseases. Then drug similarity network and disease similarity network are constructed, and they are incorporated into a heterogeneous network with known drug-disease interactions. Based on the drug-disease heterogeneous network, BiRW algorithm is adopted to predict novel potential drug-disease associations. Computational experiment results from various datasets demonstrate that the proposed approach has reliable prediction performance and outperforms several recent computational drug repositioning approaches. Moreover, case studies of five selected drugs further confirm the superior performance of our method to discover potential indications for drugs practically.AVAILABILITY AND IMPLEMENTATION: http://github.com//bioinfomaticsCSU/MBiRW CONTACT: jxwang@mail.csu.edu.cnSUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects

Biomedical Data and Computational Models for Drug Repositioning: a Comprehensive Review

Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning

A Pathway Profile-Based Method for Drug Repositioning

An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure.

Computational Drug Repositioning Using Meta-Path-based Semantic Network Analysis.

In silico drug repositioning based on drug-miRNA associations

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

Computational drug repositioning: from data to therapeutics.

Predicting drug-disease associations by network embedding and biomedical data integration.

Drug repositioning for psychiatric and neurological disorders through a network medicine approach

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

Drug Repositioning by Prediction of Drug's Anatomical Therapeutic Chemical Code Via Network-Based Inference Approaches.

Systematic Drug Repositioning Based on Clinical Side-Effects

A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus

deepDR: a network-based deep learning approach to in silico drug repositioning

Computational Drug Repositioning with Random Walk on a Heterogeneous Network